Literature DB >> 11287585

Human foamy virus capsid formation requires an interaction domain in the N terminus of Gag.

J Tobaly-Tapiero1, P Bittoun, M L Giron, M Neves, M Koken, A Saïb, H de Thé.   

Abstract

Retroviral Gag expression is sufficient for capsid assembly, which occurs through interaction between distinct Gag domains. Human foamy virus (HFV) capsids assemble within the cytoplasm, although their budding, which mainly occurs in the endoplasmic reticulum, requires the presence of homologous Env. Yet little is known about the molecular basis of HFV Gag precursor assembly. Using fusions between HFV Gag and a nuclear reporter protein, we have identified a strong interaction domain in the N terminus of HFV Gag which is predicted to contain a conserved coiled-coil motif. Deletion within this region in an HFV provirus abolishes viral production through inhibition of capsid assembly.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287585      PMCID: PMC114181          DOI: 10.1128/JVI.75.9.4367-4375.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

Review 1.  Foamy viruses: between retroviruses and pararetroviruses.

Authors:  C H Lecellier; A Saïb
Journal:  Virology       Date:  2000-05-25       Impact factor: 3.616

2.  Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.

Authors:  Y Morikawa; W H Zhang; D J Hockley; M V Nermut; I M Jones
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

3.  Multiple integrations of human foamy virus in persistently infected human erythroleukemia cells.

Authors:  C D Meiering; K E Comstock; M L Linial
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus.

Authors:  K I Pfrepper; M Löchelt; H R Rackwitz; M Schnölzer; H Heid; R M Flügel
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  Proteolytic activity, the carboxy terminus of Gag, and the primer binding site are not required for Pol incorporation into foamy virus particles.

Authors:  D N Baldwin; M L Linial
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Foamy virus capsids require the cognate envelope protein for particle export.

Authors:  T Pietschmann; M Heinkelein; M Heldmann; H Zentgraf; A Rethwilm; D Lindemann
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Isolation and characterization of an equine foamy virus.

Authors:  J Tobaly-Tapiero; P Bittoun; M Neves; M C Guillemin; C H Lecellier; F Puvion-Dutilleul; B Gicquel; S Zientara; M L Giron; H de Thé; A Saïb
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

8.  The carboxy-terminal p3Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity.

Authors:  M Zemba; T Wilk; T Rutten; A Wagner; R M Flügel; M Löchelt
Journal:  Virology       Date:  1998-07-20       Impact factor: 3.616

9.  Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue.

Authors:  J B Bowzard; R P Bennett; N K Krishna; S M Ernst; A Rein; J W Wills
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 10.  Retroviral matrix proteins: a structural perspective.

Authors:  M R Conte; S Matthews
Journal:  Virology       Date:  1998-07-05       Impact factor: 3.616

View more
  25 in total

Review 1.  Molecular biology of foamy viruses.

Authors:  Axel Rethwilm
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

2.  Protease-dependent uncoating of a complex retrovirus.

Authors:  Jacqueline Lehmann-Che; Marie-Lou Giron; Olivier Delelis; Martin Löchelt; Patricia Bittoun; Joelle Tobaly-Tapiero; Hugues de Thé; Ali Saïb
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome.

Authors:  Ingrid Mannigel; Annett Stange; Hanswalter Zentgraf; Dirk Lindemann
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

4.  Basic residues in the foamy virus Gag protein.

Authors:  Daniel Matthes; Tatiana Wiktorowicz; Juliane Zahn; Jochen Bodem; Nicole Stanke; Dirk Lindemann; Axel Rethwilm
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

5.  Intra- and intercellular trafficking of the foamy virus auxiliary bet protein.

Authors:  Charles-Henri Lecellier; Wim Vermeulen; Françoise Bachelerie; Marie-Lou Giron; Ali Saïb
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  [Comparison of several viral vectors for gene therapy of corneal endothelial cells].

Authors:  S C Beutelspacher; N Serbecic; P Tan; M O McClure
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

7.  Early reverse transcription is essential for productive foamy virus infection.

Authors:  Alessia Zamborlini; Noémie Renault; Ali Saïb; Olivier Delelis
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

8.  Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles.

Authors:  Kristin Stirnnagel; Daniel Lüftenegger; Annett Stange; Anka Swiersy; Erik Müllers; Juliane Reh; Nicole Stanke; Arend Grosse; Salvatore Chiantia; Heiko Keller; Petra Schwille; Helmut Hanenberg; Hanswalter Zentgraf; Dirk Lindemann
Journal:  Retrovirology       Date:  2010-05-17       Impact factor: 4.602

9.  Structural and evolutionary analysis of an orangutan foamy virus.

Authors:  Ernst J Verschoor; Susan Langenhuijzen; Saskia van den Engel; Henk Niphuis; Kristin S Warren; Jonathan L Heeney
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Persistent infection with primate foamy virus type 1 increases human immunodeficiency virus type 1 cell binding via a Bet-independent mechanism.

Authors:  Cecile Schiffer; Charles-Henri Lecellier; Abdelkrim Mannioui; Nathalie Felix; Elisabeth Nelson; Jacqueline Lehmann-Che; Marie-Louise Giron; Jean Claude Gluckman; Ali Saib; Bruno Canque
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.